Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongkang Yiyang appears to be a China-based health technology and health management company focused on healthcare services rather than drug development. Publicly available information links the company to cancer-prevention insurance offerings and to broader health-industry activities including chronic disease management, health check-ups, elderly-care services, and smart community medical-nursing integration. The company has been described as providing technology and health-management related services and appears to operate within a larger Chinese health-industry ecosystem associated with Ruiyuan Holdings Group. There is no clear evidence that Zhongkang Yiyang is a biotech or pharmaceutical developer with a disclosed therapeutic pipeline. Instead, it appears to be a commercial-stage healthcare services and health-tech operator serving the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongkang Yiyang Health Technology.